JanOne Inc. (JAN) Financial Analysis & Valuation | Quarter Chart
JanOne Inc. (JAN)
JANPrice: $28.8
Fair Value: 🔒
🔒score
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segme... more
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensin... more
Description
Shares
| Market Cap | $6.11B | Exchange | NASDAQ |
| Sector | Industrials | Industry | Waste Management |
| Country | US | CEO | Scott Brinker |
| IPO Date | 1991-11-07 | CAGR | 0.02% |
| Employees | 5 | Website | www.janone.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
JAN chart loading...
Fundamentals
Technicals
| Enterprise Value | $6.13B | P/E Ratio | -80 |
| Forward P/E | 135 | PEG Ratio | — |
| P/S Ratio | 285574.6 | P/B Ratio | 36911.01 |
| P/CF Ratio | -214429.43 | P/FCF Ratio | -1416179.3 |
| EPS | $-0.36 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 1253.85% | Gross Margin | 0.47% |
| Operating Margin | -0.32% | Profit Margin | -0.75% |
| ROE | -0.75% | ROA | -0.18% |
| ROCE | -0.13% | Current Ratio | 0.88 |
| Quick Ratio | 0.88 | Cash Ratio | 0.25 |
| Debt/Equity | 0.87 | Interest Coverage | -3.3 |
| Altman Z Score | 58.49 | Piotroski Score | 5 |